Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
ARK Investment Management bought 233,482 RKLB shares across ARKK, ARKQ and ARKX, worth about $16.5 million.
Bernstein, Citi, and Wells Fargo all launched bullish coverage on Coherent, Rocket Lab, and Vertiv within weeks of each other, but the real question is whether the commercial developments driving those calls can actually deliver the returns analysts are projecting.
Rocket Lab stock pushes higher on a bullish Citi note. Here’s why analyst John Godyn recommends buying RKLB shares.
Rocket Lab secures 20 additional launches for Synspective, while Citi initiates coverage with a Buy rating and $105 price target.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.